Patients With Barrett’s Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer Christine Kestens, G.

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Romy E. Verbeek, Lisanne F. Spittuler, Anique Peute, Martijn G. H

The Seattle Protocol Does Not More Reliably Predict the Detection of Cancer at the Time of Esophagectomy Than a Less Intensive Surveillance Protocol

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

How to Manage a Barrett's Esophagus Patient With Low-Grade Dysplasia

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents Christine.

Maie Abdalla, Kalle Landerholm, Peter Andersson, Roland E

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Volume 149, Issue 3, Pages e3 (September 2015)

Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient Severin Daum, Christoph Loddenkemper,

Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus Stephen E.A Attwood, Christopher J Lewis, Scott Caplin, Karla.

Volume 142, Issue 2, Pages (February 2012)

Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based.

Low Rates of Cancer or High-Grade Dysplasia in Colorectal Polyps Collected From Computed Tomography Colonography Screening Perry J. Pickhardt, Kendra.

Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study Henry P. Parkman,

Talya Salz, Robert S. Sandler Clinical Gastroenterology and Hepatology

Total Cancer Incidence and Overall Mortality Are Not Increased Among Patients With Barrett's Esophagus Leo J. Schouten, Jessie Steevens, Clément J.R.

Genetics of Colonic Polyposis

Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia Gene K. Ma, Uri Ladabaum Clinical Gastroenterology.

Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald

Activity-Based Costing and Management in a Hospital-Based GI Unit

Esophageal Adenocarcinoma 10 Years After Surgical Resection of Barrett’s Esophagus: Unusual Presentation as Subepithelial Tumor Andreas Probst, Tina.

Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased Fiona D.M. van Schaik, Martijn G.H.

Bisphosphonates Are Associated With Reduced Risk of Colorectal Cancer: A Systematic Review and Meta-analysis Siddharth Singh, Abha Goyal Singh, Mohammad.

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Endoscopic Therapy for Barrett's Esophagus

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Increased Risk of Pancreatic Adenocarcinoma After Acute Pancreatitis

When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer? Folasade P. May, Samir Gupta Clinical Gastroenterology.

Patrick Hoversten, Fouad Otaki, David A. Katzka

Su1116 US VETERANS WITH PERSISTENT INDEFINITE FOR DYSPLASIA ARE AT INCREASED RISK OF DYSPLASTIC PROGRESSION Andrew J. Henn, Kevin Song, Amy Gravely,

Dysphagia Caused by Extrinsic Esophageal Compression From Mediastinal Lymphadenopathy in Patients With Sarcoidosis Faisal Inayat, Qulsoom Hussain, Khurram.

Rohan M. Modi, Christina A. Arnold, Peter P. Stanich

Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma

Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima

Gastroenterology in a New Era of Accountability: Part 2

Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Jianguang Ji, Kari Hemminki Clinical Gastroenterology and Hepatology

Peter Bytzer Clinical Gastroenterology and Hepatology

Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis Rajesh Krishnamoorthi, Siddharth Singh, Karthik Ragunathan,

Incidence of Progression of Persistent Nondysplastic Barrett’s Esophagus to Malignancy Yonne Peters, Judith Honing, Wietske Kievit, Christine Kestens,

Rebecca M. Lovell, Alexander C. Ford

Patient-Reported Outcomes of Cirrhosis

Colorectal Cancer Screening: How to Stop a Moving Target

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-analysis Stephen P. Nguyen, Stephen Bent, Yea-Hung.

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Screening and Surveillance Colonoscopy in Chronic Crohn's Colitis: Results of a Surveillance Program Spanning 25 Years Sonia Friedman, Peter H. Rubin,

Patrícia Andrade, Susana Lopes, Guilherme Macedo

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Failure to Renew Prescriptions for Gastroprotective Agents to Patients on Continuous Nonsteroidal Anti-inflammatory Drugs Increases Rate of Upper Gastrointestinal.

Issue Highlights Clinical Gastroenterology and Hepatology

Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States Julian A. Abrams, Robert C. Kapel,

Issue Highlights Clinical Gastroenterology and Hepatology

Prateek Sharma, Gary W. Falk, Allan P

Barrett’s Esophagus in Women: Demographic Features and Progression to High-Grade Dysplasia and Cancer Gary W. Falk, Prashanthi N. Thota, Joel E. Richter,

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Thomas G. Cotter, John S. Van Arnam, John A. Schaffner

Rintaro Hashimoto, Akimichi Chonan

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Patients With Barrett’s Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer Christine Kestens, G. Johan A. Offerhaus, Jantine W.P.M. van Baal, Peter D. Siersema Clinical Gastroenterology and Hepatology Volume 14, Issue 7, Pages 956-962.e1 (July 2016) DOI: 10.1016/j.cgh.2015.12.027 Copyright © 2016 Terms and Conditions

Figure 1 Flow chart of included patients in this study. PA, pathologic. Clinical Gastroenterology and Hepatology 2016 14, 956-962.e1DOI: (10.1016/j.cgh.2015.12.027) Copyright © 2016 Terms and Conditions

Figure 2 Progression-free survival of patients with BE and confirmed (n = 161) or unconfirmed LGD (n = 1348), calculated for progression to HGD or EAC. Clinical Gastroenterology and Hepatology 2016 14, 956-962.e1DOI: (10.1016/j.cgh.2015.12.027) Copyright © 2016 Terms and Conditions

Figure 3 Flow chart of patients with initial diagnosis of (confirmed) LGD between 2005 and 2010 in the Netherlands and their follow-up diagnosis. Clinical Gastroenterology and Hepatology 2016 14, 956-962.e1DOI: (10.1016/j.cgh.2015.12.027) Copyright © 2016 Terms and Conditions